Furthermore, RUNX3 overexpression was recently shown to facilitate the development of a myelodysplastic syndrome in TET2-deficient mice, characterised by a disruption of cancer-related pathways and RUNX1-mediated haematopoiesis16. Here, RUNX3 is linked to cancer.